| MAP4K4 (HGK) | STE20 | STE | 4obp | A | A | 6-(2-fluoropyridin-4-yl)pyrido[3,2-d]pyrimidin-4-amine | Human | 2750 | |
| MAP4K4 (HGK) | STE20 | STE | 4u44 | A | A | 6-phenyl-n-(pyridin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine | Human | 2752 | |
| MAP4K4 (HGK) | STE20 | STE | 8v5i | A | | (3m)-n~6~-(1,4-dimethyl-1h-pyrazol-3-yl)-3-(1-methyl-1h-imidazol-5-yl)-2,7-naphthyridine-1,6-diamine | Human | 16224 | |
| MAP4K4 (HGK) | STE20 | STE | 4obq | B | A | - | Human | 2736 | |
| MAP4K4 (HGK) | STE20 | STE | 4u45 | B | B | - | Human | 2756 | |
| MAP4K4 (HGK) | STE20 | STE | 4u45 | B | A | - | Human | 2741 | |
| MAP4K4 (HGK) | STE20 | STE | 4obo | B | B | - | Human | 2748 | |
| MAP4K4 (HGK) | STE20 | STE | 4u44 | B | A | - | Human | 2737 | |
| MAP4K4 (HGK) | STE20 | STE | 4u3z | B | B | - | Human | 6327 | |
| MAP4K4 (HGK) | STE20 | STE | 4rvt | A | B | 3-hexanoyl-4-hydroxy-5-(4-hydroxyphenyl)pyridin-2(1h)-one | Human | 2760 | |
| MAP4K4 (HGK) | STE20 | STE | 5w5q | B | A | - | Human | 10007 | |
| MAP4K4 (HGK) | STE20 | STE | 4zk5 | A | | 8-amino-n-[1-(cyclopropylcarbonyl)azetidin-3-yl]-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide | Human | 6015 | |
| MAP4K4 (HGK) | STE20 | STE | 4u42 | A | B | 6-[(3s)-3-(4-methyl-1h-pyrazol-3-yl)piperidin-1-yl]pyrido[3,2-d]pyrimidin-4-amine | Human | 6337 | |
| MAP4K4 (HGK) | STE20 | STE | 4u3z | B | A | - | Human | 6336 | |
| MAP4K4 (HGK) | STE20 | STE | 4u42 | B | B | 6-[(3s)-3-(4-methyl-1h-pyrazol-3-yl)piperidin-1-yl]pyrido[3,2-d]pyrimidin-4-amine | Human | 6325 | |
| MAP4K4 (HGK) | STE20 | STE | 4u3y | A | A | - | Human | 6339 | |
| MAP4K4 (HGK) | STE20 | STE | 4u3z | A | A | - | Human | 6333 | |
| MAP4K4 (HGK) | STE20 | STE | 5j95 | B | | - | Human | 8000 | |
| MAP4K4 (HGK) | STE20 | STE | 4zp5 | B | | - | Human | 7090 | |
| MAP4K4 (HGK) | STE20 | STE | 4u43 | A | A | n-(pyridin-3-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine | Human | 2763 | |
| MAP4K4 (HGK) | STE20 | STE | 4u3y | B | B | - | Human | 6343 | |
| MAP4K4 (HGK) | STE20 | STE | 5di1 | A | | 4-{6-amino-5-[4-(methylsulfonyl)phenyl]pyridin-3-yl}phenol | Human | 6354 | |
| MAP4K4 (HGK) | STE20 | STE | 4u40 | A | B | phosphoaminophosphonic acid-adenylate ester | Human | 6329 | |
| MAP4K4 (HGK) | STE20 | STE | 4u40 | B | B | - | Human | 6331 | |
| MAP4K4 (HGK) | STE20 | STE | 5w5q | A | B | (5s,7s)-n~3~-methyl-10-[3-methyl-3-(5-methyl-1,3-oxazol-2-yl)but-1-yn-1-yl]-6,7-dihydro-5h-5,7-methanoimidazo[2,1-a][2]benzazepine-2,3-dicarboxamide | Human | 10005 | |
| MAP4K4 (HGK) | STE20 | STE | 4u40 | A | A | phosphoaminophosphonic acid-adenylate ester | Human | 6332 | |
| MAP4K4 (HGK) | STE20 | STE | 4u44 | B | B | - | Human | 2740 | |
| MAP4K4 (HGK) | STE20 | STE | 4u44 | A | B | 6-phenyl-n-(pyridin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine | Human | 2745 | |
| MAP4K4 (HGK) | STE20 | STE | 4u41 | B | A | - | Human | 6341 | |
| MAP4K4 (HGK) | STE20 | STE | 4obq | B | B | - | Human | 2742 | |
| MAP4K4 (HGK) | STE20 | STE | 4u41 | B | B | - | Human | 6328 | |
| MAP4K4 (HGK) | STE20 | STE | 4obp | A | B | 6-(2-fluoropyridin-4-yl)pyrido[3,2-d]pyrimidin-4-amine | Human | 2761 | |
| MAP4K4 (HGK) | STE20 | STE | 4obp | B | B | - | Human | 2757 | |
| MAP4K4 (HGK) | STE20 | STE | 4zp5 | A | | 4-[5-(4-chlorophenyl)-1,3-oxazol-2-yl]benzamide | Human | 7091 | |
| MAP4K4 (HGK) | STE20 | STE | 4u42 | A | A | 6-[(3s)-3-(4-methyl-1h-pyrazol-3-yl)piperidin-1-yl]pyrido[3,2-d]pyrimidin-4-amine | Human | 6335 | |
| MAP4K4 (HGK) | STE20 | STE | 4u43 | B | B | - | Human | 2743 | |
| MAP4K4 (HGK) | STE20 | STE | 5w5q | A | A | (5s,7s)-n~3~-methyl-10-[3-methyl-3-(5-methyl-1,3-oxazol-2-yl)but-1-yn-1-yl]-6,7-dihydro-5h-5,7-methanoimidazo[2,1-a][2]benzazepine-2,3-dicarboxamide | Human | 10008 | |
| MAP4K4 (HGK) | STE20 | STE | 4u3y | A | B | - | Human | 6340 | |
| MAP4K4 (HGK) | STE20 | STE | 4obo | A | A | 6-(3-chlorophenyl)quinazolin-4-amine | Human | 2746 | |
| MAP4K4 (HGK) | STE20 | STE | 4u45 | A | A | 6-(1h-pyrazol-4-yl)-n-(pyridin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine | Human | 2747 | |
| MAP4K4 (HGK) | STE20 | STE | 5di1 | B | | - | Human | 6353 | |
| MAP4K4 (HGK) | STE20 | STE | 4u43 | B | A | - | Human | 2753 | |
| MAP4K4 (HGK) | STE20 | STE | 4u43 | A | B | n-(pyridin-3-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine | Human | 2738 | |
| MAP4K4 (HGK) | STE20 | STE | 4rvt | B | B | - | Human | 2739 | |
| MAP4K4 (HGK) | STE20 | STE | 5j95 | A | | 1-{4-[6-amino-5-(4-chlorophenyl)pyridin-3-yl]phenyl}cyclopentane-1-carboxylic acid | Human | 7999 | |
| MAP4K4 (HGK) | STE20 | STE | 4rvt | B | A | - | Human | 2749 | |
| MAP4K4 (HGK) | STE20 | STE | 4rvt | A | A | 3-hexanoyl-4-hydroxy-5-(4-hydroxyphenyl)pyridin-2(1h)-one | Human | 2751 | |
| MAP4K4 (HGK) | STE20 | STE | 4u40 | B | A | - | Human | 6342 | |
| MAP4K4 (HGK) | STE20 | STE | 4u3y | B | A | - | Human | 6344 | |
| MAP4K4 (HGK) | STE20 | STE | 4obp | B | A | - | Human | 2754 | |
| MAP4K4 (HGK) | STE20 | STE | 4u3z | A | B | - | Human | 6326 | |
| MAP4K4 (HGK) | STE20 | STE | 4zk5 | B | | - | Human | 6014 | |
| MAP4K4 (HGK) | STE20 | STE | 5w5q | B | B | - | Human | 10006 | |
| MAP4K4 (HGK) | STE20 | STE | 4u45 | A | B | 6-(1h-pyrazol-4-yl)-n-(pyridin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine | Human | 2759 | |
| MAP4K4 (HGK) | STE20 | STE | 4obo | A | B | 6-(3-chlorophenyl)quinazolin-4-amine | Human | 2744 | |
| MAP4K4 (HGK) | STE20 | STE | 4u42 | B | A | 6-[(3s)-3-(4-methyl-1h-pyrazol-3-yl)piperidin-1-yl]pyrido[3,2-d]pyrimidin-4-amine | Human | 6330 | |
| MAP4K4 (HGK) | STE20 | STE | 4u41 | A | A | 6-[(3s)-3-(4-methyl-1h-pyrazol-3-yl)piperidin-1-yl]pyrido[3,2-d]pyrimidin-4-amine | Human | 6338 | |
| MAP4K4 (HGK) | STE20 | STE | 4u41 | A | B | 6-[(3s)-3-(4-methyl-1h-pyrazol-3-yl)piperidin-1-yl]pyrido[3,2-d]pyrimidin-4-amine | Human | 6334 | |
| MAP4K4 (HGK) | STE20 | STE | 4obq | A | A | n-[3-(4-aminoquinazolin-6-yl)-5-fluorophenyl]-2-(pyrrolidin-1-yl)acetamide | Human | 2758 | |
| MAP4K4 (HGK) | STE20 | STE | 4obo | B | A | - | Human | 2762 | |
| MAP4K4 (HGK) | STE20 | STE | 4obq | A | B | n-[3-(4-aminoquinazolin-6-yl)-5-fluorophenyl]-2-(pyrrolidin-1-yl)acetamide | Human | 2755 | |
